INS and metabolic syndrome: It has been proposed that lactisole inhibition of horse gut-expressed sweet taste receptor may have the potential for the inhibition of intestinal glucose uptake and can be used as a therapeutic strategy for the management of insulin dysregulation in horses with metabolic syndrome (31).